Found 80 matching trials
Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Denosumab 60 mg (Arylia) Versus Prolia® in Improvement of Bone Mineral Densitometry (BMD) Among Osteoporotic Postmenopausal Women PHASE3 The purpose of this study is to compare the efficacy and safety of Denosuma...
Show More Location
Rheumatology Center of Iran
Learn More & Join Trial
Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS PHASE1 This study is to compare the Pharmacokinetics, Pharmacodynamics, safety, an...
Show More Learn More & Join Trial
Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis PHASE2 The aim of this study is to determine whether denosumab (an FDA-approved os...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis PHASE3 Denosumab of Intas is biosimilar denosumab candidate under development by I...
Show More Location
S. R. Kalla Memorial Gastro & General Hospital
Learn More & Join Trial
Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone PHASE2 To determine how safe and effective denosumab is in treating patients with ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis. PHASE3 This was a randomized, double-blind, parallel, multicenter, multinational s...
Show More Location
AES - DRS - Medical Center Synexus Sofia EOOD
Learn More & Join Trial
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis PHASE4 This study will compare the effectiveness of denosumab treatment every 6 mo...
Show More Learn More & Join Trial
A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis PHASE3 This is a randomised, double-blind, multicentre study to evaluate the effic...
Show More Location
SB Investigative Site
Learn More & Join Trial
Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis PHASE3 This is a randomized, double-blind, multicenter, parallel-arm, Phase 3 stud...
Show More Location
PPD Global Ltd, Granta Park, Great Abington,
Learn More & Join Trial
Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults PHASE1 A Dual-center , Randomized, double-blinded and Parallel-controlled Study to...
Show More Location
Haikou People's Hospital
Learn More & Join Trial